BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34709030)

  • 1. Reprogramming of Neutrophils as Non-canonical Antigen Presenting Cells by Radiotherapy-Radiodynamic Therapy to Facilitate Immune-Mediated Tumor Regression.
    Guo N; Ni K; Luo T; Lan G; Arina A; Xu Z; Mao J; Weichselbaum RR; Spiotto M; Lin W
    ACS Nano; 2021 Nov; 15(11):17515-17527. PubMed ID: 34709030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy.
    Ni K; Lan G; Veroneau SS; Duan X; Song Y; Lin W
    Nat Commun; 2018 Oct; 9(1):4321. PubMed ID: 30333489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy.
    Ni K; Luo T; Culbert A; Kaufmann M; Jiang X; Lin W
    J Am Chem Soc; 2020 Jul; 142(29):12579-12584. PubMed ID: 32658476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.
    Lu K; He C; Guo N; Chan C; Ni K; Lan G; Tang H; Pelizzari C; Fu YX; Spiotto MT; Weichselbaum RR; Lin W
    Nat Biomed Eng; 2018 Aug; 2(8):600-610. PubMed ID: 31015630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo Simulation-Guided Design of a Thorium-Based Metal-Organic Framework for Efficient Radiotherapy-Radiodynamic Therapy.
    Xu Z; Luo T; Mao J; McCleary C; Yuan E; Lin W
    Angew Chem Int Ed Engl; 2022 Nov; 61(46):e202208685. PubMed ID: 36149753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale Metal-Organic Frameworks Generate Reactive Oxygen Species for Cancer Therapy.
    Ni K; Lan G; Lin W
    ACS Cent Sci; 2020 Jun; 6(6):861-868. PubMed ID: 32607433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy.
    Ni K; Lan G; Chan C; Quigley B; Lu K; Aung T; Guo N; La Riviere P; Weichselbaum RR; Lin W
    Nat Commun; 2018 Jun; 9(1):2351. PubMed ID: 29907739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tantalum-Zirconium Co-Doped Metal-Organic Frameworks Sequentially Sensitize Radio-Radiodynamic-Immunotherapy for Metastatic Osteosarcoma.
    Li T; Gao M; Wu Z; Yang J; Mo B; Yu S; Gong X; Liu J; Wang W; Luo S; Li R
    Adv Sci (Weinh); 2023 Apr; 10(10):e2206779. PubMed ID: 36739599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale Metal-Organic Layers for Radiotherapy-Radiodynamic Therapy.
    Lan G; Ni K; Veroneau SS; Song Y; Lin W
    J Am Chem Soc; 2018 Dec; 140(49):16971-16975. PubMed ID: 30485084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence, origin, and function of neutrophil-dendritic cell hybrids in experimentally induced inflammatory lesions in mice.
    Geng S; Matsushima H; Okamoto T; Yao Y; Lu R; Page K; Blumenthal RM; Ward NL; Miyazaki T; Takashima A
    Blood; 2013 Mar; 121(10):1690-700. PubMed ID: 23305733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination.
    Ni K; Lan G; Guo N; Culbert A; Luo T; Wu T; Weichselbaum RR; Lin W
    Sci Adv; 2020 Oct; 6(40):. PubMed ID: 33008911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic checkpoint-blockade and radiotherapy-radiodynamic therapy via an immunomodulatory nanoscale metal-organic framework.
    Ni K; Xu Z; Culbert A; Luo T; Guo N; Yang K; Pearson E; Preusser B; Wu T; La Riviere P; Weichselbaum RR; Spiotto MT; Lin W
    Nat Biomed Eng; 2022 Feb; 6(2):144-156. PubMed ID: 35190678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrathin metal-organic layer-mediated radiotherapy-radiodynamic therapy enhances immunotherapy of metastatic cancers.
    Ni K; Lan G; Chan C; Duan X; Guo N; Veroneau SS; Weichselbaum RR; Lin W
    Matter; 2019 Nov; 1(5):1331-1353. PubMed ID: 32832885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking of neutrophil CD11b results in rapid cell surface expression of molecules required for antigen presentation and T-cell activation.
    Sandilands GP; Ahmed Z; Perry N; Davison M; Lupton A; Young B
    Immunology; 2005 Mar; 114(3):354-68. PubMed ID: 15720437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophils, differentiated macrophages, and monocyte/macrophage antigen presenting cells infiltrate murine epidermis after UV injury.
    Cooper KD; Duraiswamy N; Hammerberg C; Allen E; Kimbrough-Green C; Dillon W; Thomas D
    J Invest Dermatol; 1993 Aug; 101(2):155-63. PubMed ID: 8393901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen-Independent Radiodynamic Therapy: Radiation-Boosted Chemodynamics for Reprogramming the Tumor Immune Environment and Enhancing Antitumor Immune Response.
    Chen Y; Deng Y; Li Y; Qin Y; Zhou Z; Yang H; Sun Y
    ACS Appl Mater Interfaces; 2024 May; 16(17):21546-21556. PubMed ID: 38626342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose X-ray radiodynamic therapy solely based on gold nanoclusters for efficient treatment of deep hypoxic solid tumors combined with enhanced antitumor immune response.
    Zhu S; Yan F; Yang L; Li B; Xue R; Yu W; Wang Y; Huang L; Wang L; Han R; Jiang Y
    Theranostics; 2023; 13(3):1042-1058. PubMed ID: 36793856
    [No Abstract]   [Full Text] [Related]  

  • 19. Murine neutrophils present Class II restricted antigen.
    Culshaw S; Millington OR; Brewer JM; McInnes IB
    Immunol Lett; 2008 Jun; 118(1):49-54. PubMed ID: 18400308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors.
    Frey B; Rückert M; Weber J; Mayr X; Derer A; Lotter M; Bert C; Rödel F; Fietkau R; Gaipl US
    Front Immunol; 2017; 8():231. PubMed ID: 28337197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.